HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
95.14%
Total 13F principal
$402,419,720
Principal change
-$792,000
Total reported market value
$386,194,906
Number of holders
28
Value change
-$866,733
Number of buys
11
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q4 2016

As of 31 Dec 2016, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 28 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $402,419,720 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT CO, KINGDON CAPITAL MANAGEMENT, L.L.C., OAKTREE CAPITAL MANAGEMENT LP, ADVENT CAPITAL MANAGEMENT /DE/, Lion Point Capital, LP, CNH PARTNERS LLC, FMR LLC, PRUDENTIAL PLC, Calamos Advisors LLC, and Nicholas Investment Partners, LP. This page lists 28 institutional bondholders reporting positions for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.